INVESTER I LINEAGE CELL THERAPEUTICS MED ENDAVU: Køb Lineage Cell Therapeutics ($LCTX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Lineage Cell Therapeutics, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic, or off-the-shelf, cell therapies for serious medical conditions. Its current programs center on cell replacement therapies for ophthalmology, neurology, hearing loss, and corneal disease, with product candidates designed to restore or replace damaged cells in targeted tissues. The company’s pipeline includes OpRegen for retinal disorders, OPC1 for spinal cord injury, COR1 for corneal endothelial disease, and other platform-based programs supported by its proprietary manufacturing and delivery capabilities. Lineage Cell Therapeutics, Inc. works at the intersection of regenerative medicine and specialty therapeutics, addressing areas of high unmet medical need through pluripotent stem cell-based technologies.